Go back to Press Releases
Sep 25 2014 Press release

Can Spinal Rods Made of PEEK-OPTIMA™ Polymer Bridge the Current Treatment Gap?


Three leading European surgeons to share their clinical findings and experience during EUROSPINE

On Wednesday 1 October at 12 noon, at EUROSPINE 2014 in Lyon, France, Invibio Biomaterials Solutions (“Invibio”) is hosting a symposium looking at how PEEK-OPTIMA Spinal Rod components offer a semi-rigid posterior fixation solution that can help bridge the gap between stiff all-metal constructs and dynamic treatment options. Invibio is a world-leading solutions provider of PEEK polymer-based biomaterials, manufacturing and R&D for medical device manufacturers.

During the session three leading European surgeons, Dr. Thierry Desjardins, Neurosurgeon (Cagnes-Sur-mer, France), Dr. Jacques Benezech (Montpellier, France) and Dr. Andreas Mavrogenis (Athens, Greece), will present individual clinical findings and discuss their experiences of using PEEK-OPTIMA spinal rods over the last three years. “The high stiffness inherent with all-metal constructs are believed to contribute to clinical challenges from rod breakage and screw loosening to accelerated degeneration at adjacent spinal segments which can all negatively impact a patient outcomes. PEEK-OPTIMA rods address these challenges and the feedback from the surgeons using these has been positive, and we’re looking forward to presenting at EUROSPINE 2014,” said Gilles Larroque, Invibio European Spine Marketing Manager.

Commenting on his planned contribution to the session, Dr. Thierry Desjardin, Neurosurgeon said “I have a lot of patients who need one level fixation and I’ve always been frightened to use too rigid a system and to destroy the adjacent levels in the future. To find a device to try to protect the adjacent level is for me very important. I think PEEK Rods can be the alternative and maybe can replace, time after time, the rigid posterior fixation.”

Device manufacturers and clinicians are invited to attend the discussion or visit the Invibio booth during the EUROSPINE 2014 meeting, #A34 in Hall 1/2/3, to learn more.

For online registration  and for more information please visit http://bridgethefusiongap.com

About Invibio Biomaterial Solutions

Invibio, a Victrex plc company, has grown significantly since pioneering PEEK
biomaterial in 1999, evolving from a materials supplier to an industry-leading provider of biomaterial solutions.  During that time the company has worked with world class research institutions, to develop and commercialize 6 implantable PEEK grades. Today, Invibio’s PEEK-OPTIMA polymers are used in more than four million implanted devices worldwide.
About Victrex plc

Victrex, headquartered in the UK, is an innovative world leader in high performance polymer solutions focused on the Aerospace, Automotive, Electronics, Energy and Medical markets. Every day, millions of people rely on products or applications which contain our polymers, from smartphones, airplanes and cars to oil & gas operations and medical devices. With over 35 years’ experience, we are investing in technical excellence to deliver leading edge solutions to our customers and our markets, and to drive value for our shareholders. Find out more at www.victrexplc.com


Invibio Biomaterial Solutions
Andrew Roberts, Invibio Marketing Communications Manager
Phone    +44 1253 898058, Mobile +44 7876 884895

Victrex media contact
Beate Sauer, PR & Marketing Communications Manager
bsauer@victrex.com, phone +49 (0) 61 92 / 96 49 19

Group or Investor Relations enquiries
Andrew Hanson, Head of Investor Relations & Communications
ahanson@victrex.com, phone: +44 12538 98121

Receive the latest clinical evidence and data for PEEK-OPTIMA based applications

By completing this form you are signing up for marketing updates. You will receive targeted messages such as newsletters, tradeshow, webinar and event announcements from Invibio, a member of the Victrex Group or on our behalf. You can unsubscribe at any time. Visit our Privacy Policy to learn more.
The materials on this site are intended for Health Care Professionals and industry users only. If you are a patient, click here, otherwise, click continue.